Navigation Links
Precyse Solutions and M*Modal Announce Breakthrough CAC Solution
Date:9/22/2010

PITTSBURGH and WAYNE, Pa., Sept. 22 /PRNewswire/ -- At the 82nd AHIMA Convention and Exhibit, Precyse Solutions, a leader in Health Information Management (HIM) services and technologies, and M*Modal, a pioneer of advanced Speech Understanding technology and provider of on-demand conversational documentation, announce their partnership to deliver a robust ICD-10-ready Computer Assisted Coding (CAC) engine in the release of PrecyseCode™, the most advanced health information management platform available today.

To best optimize coding operations and accelerate ICD-10 transition for hospitals and health systems nationwide, PrecyseCode capabilities have been built from the ground up to be ICD-10 compatible. As opposed to updating or reengineering a CAC solution to meet ICD-10 requirements, PrecyseCode has been specifically designed and engineered to be ICD-10 compatible. On the road to meaningful use of the Electronic Health Record (EHR), the HIM industry is challenged with integrating EHRs into the coding process. The CAC engine inherent in PrecyseCode now provides a bridge between EHR documentation, the transcription system and the healthcare provider's financial systems.

"Facilitating the transition, implementation and management of health information systems that support an effective and efficient healthcare system and maintain health data integrity is of paramount concern to Precyse and our customers," said Jeffrey Levitt, Chairman and CEO, Precyse Solutions.  "In this same environment, where coding staff shortages challenge providers as they simultaneously face the most significant changes ever made to our coding structure, the quality, compliance and workflow benefits that PrecyseCode delivers are critical to overcoming these obstacles."

For the past five years, Precyse has partnered with M*Modal and integrated M*Modal's sophisticated Speech Understanding technology seamlessly i
'/>"/>

SOURCE Precyse Solutions
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes
2. Three Leading Sleep Solution Providers Choose Watermark Medicals Web-Enabled Home Sleep Testing Solutions
3. Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services
4. Streamline Health® Solutions Reports Q2 Results
5. Indiana State Legislators Seek Solutions to Combat Illegal Meth Production
6. Streamline Health Document Workflow Solutions Purchased By Tampa, Florida-Based Hospital
7. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
8. MedNet Solutions Named to the Inc. 5000 List of Fastest Growing Companies for the Fourth Consecutive Year
9. Ethicon Endo-Surgery Launches EESadvancements.com for Advanced Access to Innovative Solutions
10. Premier Members to Benefit from Full Line of Market-Leading Masimo rainbow Pulse CO-Oximetry Solutions with New Agreement
11. Equinox Surgical Solutions Launches Flagship Product, SutureAssist®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... CAMBRIDGE, Mass. and HERZLIYA PITUACH, ... Inc. (OTCQX and NASDAQ OMX First North Premier, ... announces today that it has initiated the screening of ... trial exploring the safety and efficacy of bertilimumab in ... open-label trial will enroll 10-15 patients who will receive ...
(Date:7/29/2014)... 29, 2014  Sequenom, Inc. (NASDAQ: SQNM ... solutions, today reported total revenues of $39.8 million for ... compared to revenues of $24.5 million for the second ... segment, which was sold on May 30, 2014, has ... its results have been excluded from continuing operations for ...
(Date:7/29/2014)... 2014  EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... Thursday, August 7, 2014 at 11:00 AM Eastern Time ... June 30, 2014 and to provide a business update. ... quarter conference call may be accessed by dialing (877) ...
Breaking Medicine Technology:Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 4Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3
... Corporation (NASDAQ: VOLC ), a leading developer and ... the diagnosis and treatment of coronary and peripheral vascular disease, ... the third quarter of fiscal 2011 on Monday, October 31. ... discuss its financial results and operating activities open to all ...
... 17, 2011 Archimedes Pharma Ltd., and its subsidiary, ... nasal spray is now available by prescription in U.S. ... pain in cancer patients 18 years of age and ... to opioid therapy for their underlying persistent cancer pain. ...
Cached Medicine Technology:Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 2Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 3Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 4Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 5Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 6Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 7
(Date:7/29/2014)... Petersburg, FL (PRWEB) July 30, 2014 Phytceramides are ... how and why in her new book. , Today is the ... Phytoceramides: Anti Aging At Its Best . The book is also ... skin care book, but felt that Phytoceramides were so ... to bring out this focused book now," says Kathy Heshelow, founder ...
(Date:7/29/2014)... Dublin, Ireland (PRWEB) July 30, 2014 ... announced the successful completion of a Phase I trial ... Acid (DGLA). , This study was a randomized, placebo-controlled, ... to assess the safety, pharmacokinetics and effect of food ... confirmed the benign safety profile of DGLA following both ...
(Date:7/29/2014)... July 29, 2014 The Mesothelioma ... the Deadliest Cancer Coalition, led advocacy efforts among ... the newly established Congressional Caucus on the Deadliest Cancers. ... caucus now features the following 20 members: , Rep. Matt ... – May 2, 2014, Rep. Zoe Lofgren (CA-19) – June ...
(Date:7/29/2014)... they have discovered a chemical alteration in a single ... in larger studies, could give doctors a simple blood ... suicide. , The discovery, described online in The ... a gene involved in the function of the brain,s ... turning what might otherwise be an unremarkable reaction to ...
(Date:7/29/2014)... rich in soy may help feminine hearts, but timing ... Menopause , the journal of The North American ... diet of women in Asia, produces the least atherosclerosis. ... Asian migrants to North America, leads to just as ... to soy from a Western diet after menopause helps ...
Breaking Medicine News(10 mins):Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 2Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 3Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Soy may help women's hearts if they start early 2
... -- A new study finds that many American children aged ... they ride in cars -- a practice that could prove ... National Highway Traffic Safety Administration survey of nearly 900 drivers. ... 9-year-old passengers use seat belts and more than three-quarters of ...
... FRIDAY, Nov. 18 (HealthDay News) -- Although one in four ... of colon surgery, new research reveals these readmissions -- which ... The most common reason colorectal surgery patients return to ... published in the December issue of the journal Diseases ...
... computing system broke new ground earlier this year when it ... Now, The Scripps Research Institute is hoping to do something ... of the prize money from that tournament: Find a cure ... To that end, Scripps Research and IBM (NYSE: ...
... Nov. 18 (HealthDay News) -- A "tongue-tie" condition in infants ... many cases, an expert says. The condition, also known ... newborns. The most common type is easy to identify and ... tongue indentation at the front of the mouth. Another ...
... HealthDay Reporter , FRIDAY, Nov. 18 (HealthDay News) -- Those ... foods around. U.S. government health experts now encourage ... Weight Watchers, new system assigns no points to nearly all ... But, really, what,s the big deal? Why is it so ...
... rates due to colorectal cancer have declined overall, yet ... suggests that underuse of colonoscopy screening among these groups ... New York City launched a multifaceted campaign to improve ... A new study conducted by researchers at Columbia University,s ...
Cached Medicine News:Health News:Ill-Fitting Children's Seat Belts Common in U.S., Study Finds 2Health News:Colon Surgery Linked to High Readmission Rates 2Health News:Jeopardy! winnings spur IBM and Scripps Research Institute collaboration to fight against malaria 2Health News:Jeopardy! winnings spur IBM and Scripps Research Institute collaboration to fight against malaria 3Health News:Easy-to-Treat Condition Can Disrupt Breast-Feeding 2Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 2Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 3Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 4Health News:Colon cancer screening campaign erases racial, gender gaps in use of colonoscopy 2Health News:Colon cancer screening campaign erases racial, gender gaps in use of colonoscopy 3
For use with E5381 600 Circling Band (40 style). 2.2 mm diameter, 28.5 mm long....
Used with Double Tantalum Clip (250 style) E5381 852. Overall length: 7.0 mm....
Concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: wide scleral bed. Outside diameter 31.7 mm....
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Medicine Products: